Your browser doesn't support javascript.
loading
B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphoma.
Dai, Beiying; Grau, Michael; Juilland, Mélanie; Klener, Pavel; Höring, Elisabeth; Molinsky, Jan; Schimmack, Gisela; Aukema, Sietse M; Hoster, Eva; Vogt, Niklas; Staiger, Annette M; Erdmann, Tabea; Xu, Wendan; Erdmann, Kristian; Dzyuba, Nicole; Madle, Hannelore; Berdel, Wolfgang E; Trneny, Marek; Dreyling, Martin; Jöhrens, Korinna; Lenz, Peter; Rosenwald, Andreas; Siebert, Reiner; Tzankov, Alexandar; Klapper, Wolfram; Anagnostopoulos, Ioannis; Krappmann, Daniel; Ott, German; Thome, Margot; Lenz, Georg.
Afiliação
  • Dai B; Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital Münster, Münster, Germany.
  • Grau M; Cluster of Excellence EXC 1003, Cells in Motion, Münster, Germany.
  • Juilland M; Fachbereich Chemie und Pharmazie, University of Münster, Münster, Germany.
  • Klener P; Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital Münster, Münster, Germany.
  • Höring E; Cluster of Excellence EXC 1003, Cells in Motion, Münster, Germany.
  • Molinsky J; Department of Biochemistry, University of Lausanne, Epalinges, Switzerland.
  • Schimmack G; Institute of Pathological Physiology, First Faculty of Medicine, Charles University Prague, Prague, Czech Republic.
  • Aukema SM; Department of Hematology, Charles University General Hospital Prague, Prague, Czech Republic.
  • Hoster E; Department of Hematology and Oncology, Robert Bosch Hospital, Stuttgart, Germany.
  • Vogt N; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Tuebingen, Germany.
  • Staiger AM; Institute of Pathological Physiology, First Faculty of Medicine, Charles University Prague, Prague, Czech Republic.
  • Erdmann T; Department of Hematology, Charles University General Hospital Prague, Prague, Czech Republic.
  • Xu W; Research Unit Cellular Signal Integration, Institute of Molecular Toxicology and Pharmacology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
  • Erdmann K; Institute of Human Genetics, Christian-Albrechts University Kiel, Kiel, Germany.
  • Dzyuba N; Department of Internal Medicine III, Ludwig-Maximilians University Hospital Munich, Munich, Germany.
  • Madle H; Institute of Medical Informatics, Biometry, and Epidemiology, Ludwig-Maximilians University of Munich, Munich, Germany.
  • Berdel WE; Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital Münster, Münster, Germany.
  • Trneny M; Hematopathology Section and Lymph Node Registry, Department of Pathology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Dreyling M; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Tuebingen, Germany.
  • Jöhrens K; Department of Clinical Pathology, Robert Bosch Hospital, Stuttgart, Germany.
  • Lenz P; Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital Münster, Münster, Germany.
  • Rosenwald A; Cluster of Excellence EXC 1003, Cells in Motion, Münster, Germany.
  • Siebert R; Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital Münster, Münster, Germany.
  • Tzankov A; Cluster of Excellence EXC 1003, Cells in Motion, Münster, Germany.
  • Klapper W; Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital Münster, Münster, Germany.
  • Anagnostopoulos I; Cluster of Excellence EXC 1003, Cells in Motion, Münster, Germany.
  • Krappmann D; Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital Münster, Münster, Germany.
  • Ott G; Cluster of Excellence EXC 1003, Cells in Motion, Münster, Germany.
  • Thome M; Translational Oncology, Albert-Schweitzer-Campus 1, University Hospital Münster, Münster, Germany.
  • Lenz G; Cluster of Excellence EXC 1003, Cells in Motion, Münster, Germany.
Blood ; 129(3): 333-346, 2017 Jan 19.
Article em En | MEDLINE | ID: mdl-27864294

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos B / Proteínas Proto-Oncogênicas c-myc / Caspases / Linfoma de Célula do Manto / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Blood Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos B / Proteínas Proto-Oncogênicas c-myc / Caspases / Linfoma de Célula do Manto / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Blood Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha